It is demonstrated that cancer cells if express higher activity of O6-methylguanine-DNA methyltransferase (MGMT), a DNA repairing enzyme to remove TMZ-DNA adduct, may diminish the therapeutic efficacy of TMZ and appear to be more resistant and refractory to TMZ therapy. This evidence concerns the gene MGMT and cancer.